Van den Berghe's 5q- syndrome and myelodysplastic syndrome with isolated del(5q)
نویسندگان
چکیده
The del(5q) cytogenetic abnormality was first described by Van den Berghe et al. in 1974. 1 The original manuscript described five patients with a macrocytic anemia, dyserythropoiesis with erythroid hypoplasia, normal to elevated platelet count, hypolobulated megakaryocytes and an interstitial deletion involving the long arm of chromosome 5. However, a deletion of chromosome 5q in myelodysplastic syndrome (MDS) does not necessarily equate to the clinically described 5q-syndrome because, by definition, the 5q-syndrome is a distinct entity with the aforementioned clinical characteristics. 2 As we routinely evaluate patients with suspicion of MDS, some unusual clinical situations have emerged in our clinical practice. In December 2013, a 65-year-old asymptomatic woman was referred to us to investigate isolated leukopenia. The physical exam was normal. The complete blood count showed mild leukopenia (white blood cells 2.65 × 10 9 /L – neutrophils 36%, eosinophils 8%, basophils 0%, lymphocytes 48% and monocytes 8%), hemoglobin 12.3 g/dL (normal range 11.5–16.4 g/dL), mean corpuscular volume (MCV) 101.1 fL and platelets 326 × 10 9 /L. The patient was submitted to bone marrow (BM) aspiration and biopsy, as well as cytogenetic analysis by G-banding. The BM smear revealed a normocellular erythrocyte lin-eage, characterized by the presence of dysplasia in 12% of cells. The megakaryocytic lineage was hypercellular and characterized by dysplasia in 28% of cells. The morphologically abnormal megakaryocytes exhibited a non-lobulated, eccentric nucleus (Figure 1a). Occasionally, 'dumbbell-type' megakaryocytes were identified (Figure 1b). The BM biopsy showed overall hypocellularity and confirmed the significant dysmegakaryopoiesis. Dyserythro-poiesis was characterized by megaloblastoid erythroblasts (<10%). The granulocytic series showed no significant abnormalities. Following the recommendations of the International System for Human Cytogenetic Nomenclature (ISCN 2013), the cytogenetic analysis demonstrated a karyotype with a large interstitial deletion in the long arm of chromosome 5 (5q22) in 50% of 16 analyzed metaphases (46,XX,del(5)(q22)[8]/46,XX[8]) (Figure 1c). The patient's last medical consultation took place in June 2015 and she was asymptomatic. She continues to be followed by her local hematologist. In March 2015, the hemoglobin level dropped to 10.6 g/dL. The last complete blood count dated June 2015 showed white blood cells of 1.64 × 10 9 /L – neutrophils 23.9%, eosinophils 5.2%, basophils 0.5%, lymphocytes 61.6%, monocytes 8.8% – hemoglobin 9.9 g/dL, MCV 109.1 fL, and platelets 195 × 10 9 /L. The median value and the minimum–maximum value for hemoglobin, and neutrophil and platelet counts during the period of the follow up were Myelodysplastic …
منابع مشابه
Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.
Myelodysplastic syndromes (MDS) with isolated deletion of chromosome arm 5q (del(5q)) have a good prognosis with low risk of transformation to acute myeloid leukemia (AML). Laboratory investigations typically demonstrate macrocytic anemia with preserved or increased platelet counts, and characteristic hypolobated megakaryocytes in the marrow (Figure 1A). Recent studies have provided significant...
متن کاملRecent Advances in the 5q- Syndrome
The 5q- syndrome is the most distinct of the myelodysplastic syndromes (MDS) and patients with this disorder have a deletion of chromosome 5q [del(5q)] as the sole karyotypic abnormality. Several genes mapping to the commonly deleted region of the 5q- syndrome have been implicated in disease pathogenesis in recent years. Haploinsufficiency of the ribosomal gene RPS14 has been shown to cause the...
متن کاملDifferential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome
BACKGROUND Myelodysplastic syndrome with isolated chromosome 5q deletion (5q- syndrome) is a clonal stem cell disorder characterized by ineffective hematopoiesis. MicroRNAs (miRNAs) are important regulators of hematopoiesis and their aberrant expression was detected in some clonal hematopoietic disorders. We thus analyzed miRNA expressions in bone marrow CD34+ cells of 5q- syndrome patients. Fu...
متن کاملCorrelation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome.
We examined whether lenalidomide exposure up-regulates miRNAs and mRNAs, previously shown to play a role in the disease phenotype of del(5q) myelodysplastic syndrome, in pre-treatment CD34(+) marrow cells. We hypothesized that increased expression would predict for clinical response. Changes in miR-143, miR-145, miR-146a, miR-146b, miR-378, miR-584, SPARC and RPS14 were examined in del(5q) (n=1...
متن کاملGenome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
BACKGROUND We undertook a genome wide single nucleotide polymorphism analysis of a spectrum of patients with myelodysplastic syndrome del(5q) in order to investigate whether additional genomic abnormalities occur. Single nucleotide polymorphism array analysis has been shown to detect not only gene deletions but also regions of uniparental disomy that can pinpoint particular regions for mutation...
متن کامل